Appeal No. 1998-2948
Application 08/400,861
We refer to the Final Rejection (Paper No. 5), the
Examiner's Answer (Paper No. 11) (pages referred to as
"EA__"), the Supplemental Examiner's Answer (Paper No. 14),
and the [Second] Supplemental Examiner's Answer (Paper No. 16)
for a statement of the Examiner's position, and to the Appeal
Brief (Paper No. 10) (pages referred to as "Br__"), the Reply
Brief (Paper No. 12) (pages referred to as "RBr__"), the
Supplemental Reply Brief (Paper No. 15) (pages referred to as
"SRBr__"), and the Second Supplemental Reply Brief (Paper
No. 17) (pages referred to as "2dSRBr__") for a statement of
Appellants' arguments thereagainst.
OPINION
Only argued limitations and arguments in the brief are
addressed
We only address the argued limitations and the arguments
which are made in the briefs. See 37 CFR § 1.192(c)(8)(iv)
(1996) (brief is required to specify the specific limitations
in the rejected claims which are not described in the prior
art or rendered obvious over the prior art). Cf. In re Baxter
Travenol Labs., 952 F.2d 388, 391, 21 USPQ2d 1281, 1285 (Fed.
Cir. 1991) ("It is not the function of this court to examine
- 7 -
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007